Friday Pre-Market Top Gainers $SQFT $MREO $SNOA

ThinkorSwim App NOT Working Market Open/Close (MUST KNOW Nasdaq Opening & Closing Crosses)

need to know glitch from nasdaq routing

$700 lesson Full live video here: https://youtu.be/CIRK77EZy7I

CYTH [NASD]

82% 8mc 2f

Director buying and $12 price target

MREO [NASD]

50% 150mc 21f

Dec-17-20 04:05PM	Ultragenyx and Mereo BioPharma Announce Collaboration and License Agreement for Setrusumab in Osteogenesis Imperfecta GlobeNewswire
04:05PM	Mereo BioPharma and Ultragenyx Announce Collaboration and License Agreement for Setrusumab in Osteogenesis Imperfecta GlobeNewswire
Dec-15-20 01:00PM	Mereo BioPharma Provides Update on AIM Delisting and Continued Listing of its ADSs on Nasdaq, and Provides Update on agreements with Silicon Valley Bank and Kreos Capital GlobeNewswire +8.46%
Dec-07-20 10:59PM	Is MREO A Good Stock To Buy Now? Insider Monkey

CNSP [NASD]

40% 44mc 7f

Dec-17-20 04:05PM	CNS Pharmaceuticals Announces Call to Discuss FDA IND Approval and Phase 2 Trial for Berubicin PR Newswire +14.68%
09:00AM	CNS Pharmaceuticals Announces FDA Approval of IND Application for its Brain Cancer Drug Candidate Berubicin PR Newswire
Dec-16-20 08:30AM	InvestorBrandNetwork Announces Want Money Got Money Podcast with CNS Pharmaceuticals Inc. Chairman and CEO John Climaco GlobeNewswire
Nov-24-20 08:00AM	CNS Pharmaceuticals Featured in Syndicated Broadcast Covering Recent Announcements for Glioblastoma Multiforme (GBM) Therapy GlobeNewswire